These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 18070540)

  • 21. [Follow up results and pathogenetic substantiation of the effect of decompression surgery on the optic nerve in glaucomatous optic neuropathy].
    Shmyreva VF; Mostovoĭ EN; Shmeleva OA
    Vestn Oftalmol; 2001; 117(2):3-5. PubMed ID: 11510162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
    Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Glial cell and glaucomatous optic neuropathy].
    Ling ZH; Sun XH
    Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):85-8. PubMed ID: 22490920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immune response in glaucoma: a perspective on the roles of oxidative stress.
    Tezel G
    Exp Eye Res; 2011 Aug; 93(2):178-86. PubMed ID: 20709058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant.
    Thanos S; Naskar R
    Exp Eye Res; 2004 Jul; 79(1):119-29. PubMed ID: 15183107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What changes can we expect in the brain of glaucoma patients?
    Gupta N; Yücel YH
    Surv Ophthalmol; 2007 Nov; 52 Suppl 2():S122-6. PubMed ID: 17998036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
    Hains BC; Waxman SG
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic potentials of aspirin in glaucomatous optic neuropathy.
    Attarzadeh A; Hosseini H; Nowroozizadeh S
    Med Hypotheses; 2006; 67(2):375-7. PubMed ID: 16527427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glaucoma as primary optic neuropathy].
    Nicolae A; Stefan C
    Oftalmologia; 2001; 54(4):5-8. PubMed ID: 12035602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Glaucomatous optic neuropathy. Its etiopathogenetic aspects; the therapeutic consequences].
    Apostol S
    Oftalmologia; 1998; 44(3):13-6. PubMed ID: 10418606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphologic changes in chronic high-pressure experimental glaucoma in rhesus monkeys.
    Hayreh SS; Pe'er J; Zimmerman MB
    J Glaucoma; 1999 Feb; 8(1):56-71. PubMed ID: 10084276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotection in Glaucoma: Animal Models and Clinical Trials.
    Almasieh M; Levin LA
    Annu Rev Vis Sci; 2017 Sep; 3():91-120. PubMed ID: 28731838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotection and regeneration in glaucoma.
    Levin LA
    Ophthalmol Clin North Am; 2005 Dec; 18(4):585-96, vii. PubMed ID: 16314221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elastosis of the lamina cribrosa in glaucomatous optic neuropathy.
    Pena JD; Netland PA; Vidal I; Dorr DA; Rasky A; Hernandez MR
    Exp Eye Res; 1998 Nov; 67(5):517-24. PubMed ID: 9878213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential treatment modalities for glaucomatous neuropathy: neuroprotection and neuroregeneration.
    Schwartz M; Belkin M; Yoles E; Solomon A
    J Glaucoma; 1996 Dec; 5(6):427-32. PubMed ID: 8946301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central corneal thickness correlated with glaucoma damage and rate of progression.
    Jonas JB; Stroux A; Velten I; Juenemann A; Martus P; Budde WM
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1269-74. PubMed ID: 15790889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulating the immune system: a vaccine for glaucoma?
    Schwartz M
    Can J Ophthalmol; 2007 Jun; 42(3):439-41. PubMed ID: 17508041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autophagy dysregulation and the fate of retinal ganglion cells in glaucomatous optic neuropathy.
    Russo R; Nucci C; Corasaniti MT; Bagetta G; Morrone LA
    Prog Brain Res; 2015; 220():87-105. PubMed ID: 26497786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of HLA-DR expression in human lamina cribrosa astrocytes by cytokines and simulated ischemia.
    Yang J; Yang P; Tezel G; Patil RV; Hernandez MR; Wax MB
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):365-71. PubMed ID: 11157868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.